Total Payments
$243,195
2024 Payments
$1,890
Companies
45
Transactions
275
Payment Breakdown by Category
Research$237,388 (97.6%)
Food & Beverage$4,780 (2.0%)
Travel$1,021 (0.4%)
Education$6.02 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $237,388 | 3 | 97.6% |
| Food and Beverage | $4,780 | 266 | 2.0% |
| Travel and Lodging | $1,021 | 5 | 0.4% |
| Education | $6.02 | 1 | 0.0% |
Payments by Type
Research
$237,388
3 transactions
General
$5,807
272 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Eli Lilly and Company | $237,388 | 3 | $0 (2023) |
| ModernaTX, Inc. | $1,321 | 10 | $0 (2024) |
| ABBVIE INC. | $459.15 | 20 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $340.47 | 20 | $0 (2024) |
| Shire North American Group Inc | $287.01 | 28 | $0 (2019) |
| Allergan, Inc. | $242.97 | 23 | $0 (2020) |
| AstraZeneca Pharmaceuticals LP | $223.86 | 15 | $0 (2020) |
| CSL Behring | $212.31 | 8 | $0 (2024) |
| Lilly USA, LLC | $202.08 | 11 | $0 (2024) |
| Avanir Pharmaceuticals, Inc. | $194.74 | 8 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,890 | 37 | ModernaTX, Inc. ($1,321) |
| 2023 | $237,122 | 16 | Eli Lilly and Company ($236,777) |
| 2022 | $1,104 | 18 | Eli Lilly and Company ($611.00) |
| 2021 | $212.06 | 12 | Takeda Pharmaceuticals U.S.A., Inc. ($68.49) |
| 2020 | $639.80 | 45 | Allergan, Inc. ($116.18) |
| 2019 | $332.95 | 22 | Shire North American Group Inc ($80.02) |
| 2018 | $595.41 | 46 | Shire North American Group Inc ($156.20) |
| 2017 | $1,298 | 79 | Novo Nordisk Inc ($141.40) |
All Payment Transactions
275 individual payment records from CMS Open Payments — Page 1 of 11
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/10/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $8.24 | General |
| Category: NEUROSCIENCE | ||||||
| 12/02/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $16.14 | General |
| Category: NEUROSCIENCE | ||||||
| 11/19/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $19.58 | General |
| Category: NEUROSCIENCE | ||||||
| 11/15/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $18.82 | General |
| Category: Biological | ||||||
| 11/13/2024 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $21.43 | General |
| Category: Insomnia | ||||||
| 10/28/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $6.78 | General |
| Category: NEUROSCIENCE | ||||||
| 10/15/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $7.73 | General |
| Category: NEUROSCIENCE | ||||||
| 10/08/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $20.22 | General |
| Category: NEUROSCIENCE | ||||||
| 09/05/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $116.01 | General |
| Category: RESPIRATORY | ||||||
| 08/27/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $20.96 | General |
| Category: NEUROSCIENCE | ||||||
| 08/19/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $5.12 | General |
| Category: NEUROSCIENCE | ||||||
| 07/29/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: NEUROSCIENCE | ||||||
| 07/17/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $20.33 | General |
| Category: Diabetes Care | ||||||
| 07/02/2024 | CSL Behring | Haegarda (Biological) | Food and Beverage | In-kind items and services | $39.36 | General |
| Category: Immunology | ||||||
| 07/01/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $15.25 | General |
| Category: NEUROSCIENCE | ||||||
| 06/26/2024 | Paratek Pharmaceuticals, Inc. | NUZYRA (Drug) | Food and Beverage | In-kind items and services | $22.15 | General |
| Category: ANTIBIOTIC | ||||||
| 06/24/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $3.89 | General |
| Category: NEUROSCIENCE | ||||||
| 06/18/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $15.33 | General |
| Category: RESPIRATORY | ||||||
| 06/12/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $21.59 | General |
| Category: Diabetes | ||||||
| 06/10/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $17.03 | General |
| Category: NEUROSCIENCE | ||||||
| 05/28/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $29.46 | General |
| Category: Biological | ||||||
| 04/22/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $23.11 | General |
| Category: NEUROSCIENCE | ||||||
| 03/06/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $19.20 | General |
| Category: Diabetes | ||||||
| 03/04/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $22.02 | General |
| Category: NEUROSCIENCE | ||||||
| 01/22/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $16.06 | General |
| Category: NEUROSCIENCE | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| A PHASE 4 RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROLLED STUDY EVALUATING THE EFFICACY AND SAFETY OF GALCANEZUMAB VERSUS RIMEGEPANT IN ADULT PARTICIPANTS WITH EPISODIC MIGRAINE | Eli Lilly and Company | $236,777 | 2 |
| A PHASE 4, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY EVALUATING THE EFFICACY AND SAFETY OF GALCANEZUMAB VERSUS RIMEGEPANT IN ADULT PARTICIPANTS WITH EPISODIC MIGRAINE | Eli Lilly and Company | $611.00 | 1 |
About Dr. Robert Springer, M.D
Dr. Robert Springer, M.D is a Internal Medicine healthcare provider based in Atlanta, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/28/2006. The National Provider Identifier (NPI) number assigned to this provider is 1306850987.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Robert Springer, M.D has received a total of $243,195 in payments from pharmaceutical and medical device companies, with $1,890 received in 2024. These payments were reported across 275 transactions from 45 companies. The most common payment nature is "" ($237,388).
Ad
Practice Information
- Specialty Internal Medicine
- Location Atlanta, GA
- Active Since 07/28/2006
- Last Updated 05/15/2008
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1306850987
Products in Payments
- QULIPTA (Drug) $307.95
- VYVANSE (Drug) $305.45
- MOUNJARO (Drug) $186.54
- ONZETRA Xsail (Drug) $183.14
- Trintellix (Drug) $171.47
- UBRELVY (Drug) $156.81
- Dayvigo (Drug) $154.39
- NURTEC ODT (Drug) $147.90
- Nucynta (Drug) $120.45
- AREXVY (Drug) $116.01
- TRINTELLIX (Drug) $110.86
- VRAYLAR (Drug) $110.57
- Xultophy 100/3.6 (Drug) $105.55
- FARXIGA (Drug) $102.92
- Multiple Products (Biological) $101.59
- Aimovig (Biological) $97.92
- TREXIMET (Drug) $96.01
- Haegarda (Biological) $91.93
- Descovy (Drug) $90.99
- MYDAYIS (Drug) $85.46
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Atlanta
Dr. Nitin Gupta, M.d, M.D
Internal Medicine — Payments: $1.2M
Internal Medicine $1.2M
Dr. Zandraetta Tims-Cook, Md, Mph, MD, MPH
Internal Medicine — Payments: $648,799
Internal Medicine $648,799
Brian Pearlman, Md, MD
Internal Medicine — Payments: $588,483
Internal Medicine $588,483
Tracey Henry
Internal Medicine — Payments: $304,663
Internal Medicine $304,663
Michael Lloyd, Md, MD
Internal Medicine — Payments: $276,236
Internal Medicine $276,236
Dr. Ebon Bourne, M.d, M.D
Internal Medicine — Payments: $196,841
Internal Medicine $196,841